申请人:BRISTOL MYERS SQUIBB CO
                            
                            
                                公开号:WO2015069594A1
                            
                            
                                公开(公告)日:2015-05-14
                            
                            The disclosure generally relates to compounds of formula I, including their salts, as well as compositions and methods of using the compounds to treat disorders associated with GSK-3.
                            披露通常涉及到公式I的化合物,包括它们的盐,以及使用这些化合物治疗与GSK-3相关疾病的组合物和方法。